Linking cholesterol metabolism in myeloid cells to remyelination in mice and humans

B07

This project addresses a fundamental question in the field of multiple sclerosis, namely why remyelination mostly fails in progressive MS. Myeloid cells are the dominating inflammatory cell population in active and mixed active/inactive MS lesions. Our recent animal experiments demonstrated that accumulation of myelin debris in myeloid cells can induce a maladaptive immune response that impedes remyelinationm. Yet the mechanisms underlying the block of myelin repair are unknown. We want to understand how different functional states of myeloid cells are linked to oligodendrocytes and remyelination in MS lesions. These are our main questions::

    1. How does cholesterol clearance in phagocytes affect oligodendrocytes and remyelination in demyelinating animal models?
    2. Are lipidated particles that are formed after myelin debris clearance reutilized by oligodendrocytes and required for remyelination?
    3. How do supernatants from phagocytes at different stages of cholesterol clearance affect oligodendroglial differentiation, migration, myelination or cell death? What are the underlying molecular mechanisms?
    4. Do supernatants from phagocytes at different stages of cholesterol clearance induce cellular senescence in oligodendrocytes?
    5. Are different stages of cholesterol clearance associated with lesion activity or ongoing or impaired remyelination?

 

 

 

 

 

 

 

 

 

 

 

 

 

Principal Investigators:

Univ.-Prof. Dr. med. Tanja Kuhlmann
Institut für Neuropathologie
Münster
tanja.kuhlmann@ukmuenster.de

Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München
msimons@gwdg.de

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more